Lexington, MA, United States of America

Anil Kumar Padyana

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 30(Granted Patents)


Location History:

  • Oxford, CT (US) (2013 - 2016)
  • Lexington, MA (US) (2018 - 2024)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Anil Kumar Padyana: Innovator in Pharmaceutical Research

Introduction

Anil Kumar Padyana is a distinguished inventor based in Lexington, MA, known for his significant contributions to pharmaceutical research. With a total of 14 patents to his name, he has made remarkable strides in developing innovative treatments for various medical conditions.

Latest Patents

Among his latest patents is the invention of substituted benzamides as RIPK2 inhibitors for the treatment of inflammatory bowel disease. This invention relates to compounds of a specific formula, including pharmaceutically acceptable salts, and encompasses pharmaceutical compositions and methods for treating various diseases. Another notable patent involves pyruvate kinase activators for treating blood disorders. This patent describes compounds that activate pyruvate kinase, along with pharmaceutical compositions and methods of use.

Career Highlights

Anil Kumar Padyana has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Agios Pharmaceuticals, Inc. His work has significantly impacted the development of new therapeutic strategies.

Collaborations

Throughout his career, Anil has collaborated with esteemed colleagues such as Giovanni Cianchetta and Tao Liu, contributing to the advancement of pharmaceutical innovations.

Conclusion

Anil Kumar Padyana's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations highlight his commitment to improving healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…